Traditional Chinese Medicine (TCM) applied in the clinic as a complementary and alternative therapy has helped improve immunity and reduce side effects and symptomatic treatment in patients with HIV/AIDS. However, the mechanisms of TCM syndromes are not clear. Transcriptomics enables the study of such TCM syndromes.
Design:
This study compared the messenger RNA (mRNA) expressions of healthy persons and patients with HIV/AIDS who had two common TCM syndromes, qi-yin deficiency and dampness-heat retention, to find the difference in HIV/AIDS with TCM syndromes.
Results:
Comparison with healthy persons identified 113 mRNAs—41 enhanced and 72 decreased—in the qi-yin deficiency group. Additionally, 76 mRNAs were found in the dampness-heat retention group: 14 increased and 62 decreased. Functional genetic analysis of the mRNAs indicated that two TCM syndromes were correlated with cell apoptosis, immunoinflammatory responses, and lymphocyte activation. Differentially expressed mRNAs in the qi-yin deficiency group were obviously associated with cellular activity, communication, protein localization, cellular ion homeostasis, and regulation of cell motion, whereas mRNAs in the dampness-heat retention group were associated with sequence-specific DNA binding, cellular response to stress, and hemopoietic or lymphoid organ development.
Conclusions:
These results suggest that the formation of different TCM syndromes in patients with HIV/AIDS were founded on biological transcriptomics, which reveal mechanisms of the formation of these syndromes in HIV/AIDS. Differentially expressed mRNAs in two TCM syndrome groups tended to normalize after TCM intervention, which indicates that TCM might remit symptoms by changing genetic expression.
Get full access to this article
View all access options for this article.
References
1.
MbitaZ, HullR, DlaminiZ. Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets. Viruses, 2014; 6:3181–3227.
2.
DybulM, FauciAS, BartlettJG, et al.Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med, 2002; 137:381–433.
3.
LiuA, LiJ, YeJ, et al.Clinical observation of efficacy and safety of second-line antiretroviral therapy in HIV/AIDS. Chin J AIDS STD, 2015; 2:450–452.
4.
MikhailIS, DiClementeR, PersonS, et al.Association of complementary and alternative medicines with HIV clinical disease among a cohort of women living with HIV/AIDS. J Acquir Immune Defic Syndr, 2004; 37:1415–1422.
5.
Owen-SmithA, DiclementeR, WingoodG. Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women. AIDS Care, 2007; 19:589–593.
6.
DhallaS, ChanKJ, MontanerJS, et al.Complementary and alternative medicine use in British Columbia–a survey of HIV positive people on antiretroviral therapy. Complement Ther Clin Pract, 2006; 12:242–248.
7.
WangJ, LiangB, ZhangX, et al.An 84-month observational study of the changes in CD4 T-lymphocyte cell count of 110 HIV/AIDS patients treated with traditional Chinese medicine. Front Med, 2014; 8:362–367.
8.
ZhaoHX, ZhangFJ, HanN, et al. [Effects of traditional Chinese medicine on CD4+ T cell counts and HIV viral loads during structured treatment interruption in highly active antiretroviral therapy]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2006; 28:658–661.
9.
ChenX, YangZ, ShenF, et al.Curative effect of fufang qizhu tang in pixu (spleen deficient) syndrome of patients with HIV/AIDS and the influence of CD4 T lymphocytes in peripheral blood. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai, 2010; 24:40–42.
10.
ChenR, SnyderM. Systems biology: personalized medicine for the future?. Curr Opin Pharmacol, 2012; 12:623–628.
11.
NiuX. Discussion on the application of molecular biology techniques in the research of TCM Syndrom. Chin J Basic Med Trad Chinese Med, 2014; 20:1510–1512.
12.
WuM, WuM. Correlation of molecular biology techniques and disease of TCM syndromes studies. J Trad Chin Med, 2002; 43:8–10.
13.
XuQ, YanX, WuX. Transcriptomics in the fight against AIDS medicine TCM syndrome research applications. China J Chin Med, 2014; 29:309–311.
14.
LiX, LiangY, LiJ, et al.Research of systems biology and the essence of TCM syndrome. Chin J Basic Med Trad Chin Med, 2011; 17:211–212.
15.
XieS, ZuoG. Use of systems biology in research of TCM syndromes. World Chin Med, 2011; 6:369–371.
16.
ZhangA, SunH, WangP, et al.Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. Complement Ther Med, 2012; 20:93–99.
17.
LiYP, ZhaoY, DengJG. Development and analysis on TCM treatment on experimental research on HIV /AIDS animals. Jilin J Trad Chin Med, 2014; 34:993–995.
18.
ZhangXW. Research progress on HIV/AIDS treatment with traditional Chinese medicine. Chin Med Modern Distance Educ China, 2008; 6:86–88.
19.
YanSL, ShenHC, WangHZ, et al.Research to three kinds of disease kidney yang syndrome. “Treating same syndrome with different method” at signal transduction pathways. J Yunnan Coll Trad Chin Med, 2012; 35:5–9.
20.
YangC, LiuH, WangL. Study on the differential gene expressions of chronic hepatitis B patients of gan depression pi deficiency syndrome and pi-wei damp-heat syndrome. Chin J Integr Trad Western Med, 2012; 32:1032–1037.
21.
LiMD, CaoJ, WangS, et al.Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat. PloS One, 2013; 8:e59582.
22.
XuWW, HanMJ, ChenD, et al.Genome-wide search for the genes accountable for the induced resistance to HIV-1 infection in activated CD4+ T cells: apparent transcriptional signatures, co-expression networks and possible cellular processes. BMC Med Genom, 2013; 6:15.
23.
QiuH, XieSP, GuoXX. Epidemiology distribution of TCM syndromes of 274 patients with HIV/AIDS. J Zhengzhou Univ Med Sci, 2007; 42:363–364.
24.
LiQ, WangYL, WangYH. Epidemiology and TCM syndrome type distribution of 168 patients with HIV/AIDS. Fujian J Trad Chin Med, 2007; 38:4–6.
25.
QinGZ, LiQS, ZhangCH. Disease occurrence characteristics of TCM and database established of TCM syndromes study of AIDS. J Yunnan Coll Trad Chin Med, 2008; 2:43–45.
26.
ShiX. Statistical Modeling of AIDS Syndromes. Guangzho, China: Guangzhou University of Chinese Medicine, 2008.
27.
ChenXH. Quantitative Study of Common Excess Syndrome of AIDS. Zhengzhou, China: Henan University of Traditional Chinese Medicine, 2008.
28.
XuQL, WuXW, XieSP, et al.Study on standardization research of AIDS traditional Chinese medicine syndromes. Chin J Exp Trad Med Form, 2012; 17:096.
29.
DengZJ. Pharmacology of traditional Chinese medical formulae. China Pr Trad Med, 2007; 10:156.
30.
LinPZ. Science of seasonal febrile disease. China Pr Trad Med, 2007; 1:218.
31.
YueFY, KovacsCM, DimayugaRC, et al.Preferential apoptosis of HIV-1-specific CD4+ T cells. J Immunol, 2005; 174:2196–2204.
32.
SperberK, BeuriaP, SinghaN. Induction of apoptosis by HIV-I-infected monocytic cells. J Immunol, 2003; 170:1566–1578.
33.
DerksRA, BeamanKD. Regeneration and tolerance factor prevents bystander T-cell death associated with human immunodeficiency virus infection. Clin Diagnost Lab Immunol, 2004; 11:835–840.
34.
ChenF, CastranovaV, ShiX. New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol, 2001; 159:387–397.
35.
FiumeG, VecchioE, De LaurentiisA, et al.Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65. Nucleic Acids Res, 2012; 40:3548–3562.
36.
HermanMD, NymanT, WelinM, et al.Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim. FEBS Lett, 2008; 582:3590–3594.
37.
BarshackI, Lithwick-YanaiG, AfekA, et al.MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol Res Pract, 2010; 206:578–584.
38.
RothsteinTL. Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res, 2000; 10:245–266.
39.
PatroSC, PalS, BiY, et al.Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects. J Virol, 2015; 89:799–810.
40.
KleinW, TrommA, FolwacznyC, et al.A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis, 2004; 19:153–156.
41.
WangJH, WangYY, OuyangDY, et al.Apoptosis in human immunodeficiency virus infection. Zoologic Res, 2002; 23:514–520.
42.
FengY, HuJ, MaJ, et al.RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Eur J Cancer, 2011; 47:2353–2363.
43.
Oswald-RichterK, GrillSM, LeelawongM, et al.Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. PLoS Pathogens, 2007; 3:e58.
44.
HutterG, NowakD, MossnerM, et al.Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med, 2009; 360:692–698.
45.
Ruibal-AresBH, BelmonteL, BarePC, et al.HIV-1 infection and chemokine receptor modulation. Curr HIV Res, 2004; 2:39–50.
46.
CataniMV, CorasanitiMT, NavarraM, et al.gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem, 2000; 74:2373–2379.
47.
BiHJ, WangJ. Expression of CXCR1, CXCR2 and EL-8 in Peripheral Blood of Liver Cirrhosis Patients. Anhui Province, China: Anhui University of Science & Technology, 2012; 5:1–21.
48.
GlienkeW, EsserR, von BriesenH, et al.Cytokine expression of HIV-infected monocytes/macrophages at the single-cell level. Res Virol, 1994; 145:193–197.
49.
ConaldiPG, SerraC, DoleiA, et al.Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha. J Med Virol, 1995; 47:355–363.
50.
PontilloA, OshiroTM, GirardelliM, et al.Polymorphisms in inflammasome genes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr, 2012; 59:121–125.
51.
KocA, BatarB, CelikO, et al.Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population. Immunobiology, 2014; 219:531–536.
52.
AliS, HirschfeldAF, MayerML, et al.Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia. J Immunol, 2013; 190:3949–3958.
53.
MhandireK, DuriK, KandawasvikaG, et al.CCR2, CX3CR1, RANTES and SDF1 genetic polymorphisms influence HIV infection in a Zimbabwean pediatric population. J Infect Developing Countries, 2014; 8:1313–1321.
54.
DengR, CassadyK, LiX, et al.B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease. J Immunol, 2015; 194:560–574.
55.
Ostrand-RosenbergS, HornLA, HaileST. The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity. J Immunol, 2014; 193:3835–3841.
56.
LeeKA, GayCL, LerdalA, et al.Cytokine polymorphisms are associated with fatigue in adults living with HIV/AIDS. Brain Behav Immun, 2014; 40:95–103.
57.
LiHF, LiuY, LuoBD. Expression of NF-kB in liver of hepatitis-virus febrile disease dampness-heat syndrome model mice. J New Chin Med, 2012; 44:152–154.
58.
XingH, LaoS. Expression of IL-8 and HsP70 in HP-Related Gastropathy Spleen-Stomach Damp-Heat Syndrome. Guangzhou, China: Guangzhou University of Chinese Medicine, 2009; 4:9–12.
59.
ZhangXQ, J. F. HIV Virus and AIDS. Beijing: People's Medical Publishing House, 1999.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
